Pat Dorsey's RPRX Position Overview
Pat Dorsey (via Dorsey Asset Management, LLC) currently holds 2.4M shares of Royalty Pharma plc (RPRX) worth $82.92 M, representing 7.45% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Pat Dorsey has initiated a new position in RPRX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Pat Dorsey's Royalty Pharma plc (RPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Royalty Pharma plc (RPRX) Trades by Pat Dorsey
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +2.35 M | New Buy | 2.35 M | $35.28 |
Pat Dorsey's Royalty Pharma plc Investment FAQs
Pat Dorsey first purchased Royalty Pharma plc (RPRX) in Q3 2025, acquiring 2,350,449 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Pat Dorsey has held Royalty Pharma plc (RPRX) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Pat Dorsey's largest addition to Royalty Pharma plc (RPRX) was in Q3 2025, adding 2,350,449 shares worth $82.92 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Pat Dorsey's firm, Dorsey Asset Management, LLC, owns 2,350,449 shares of Royalty Pharma plc (RPRX), valued at approximately $82.92 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Royalty Pharma plc (RPRX) represents approximately 7.45% of Pat Dorsey's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Pat Dorsey's peak holding in Royalty Pharma plc (RPRX) was 2,350,449 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.